Koninklijke Philips N.V. (PHG)
USD 25.59
(2.44%)
USD 25.59
(2.44%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 29.4 Billion EUR | -4.18% |
| 2022 | 30.68 Billion EUR | -0.88% |
| 2021 | 30.96 Billion EUR | 11.72% |
| 2020 | 27.71 Billion EUR | 2.71% |
| 2019 | 26.98 Billion EUR | 3.7% |
| 2018 | 26.01 Billion EUR | 2.78% |
| 2017 | 25.31 Billion EUR | -21.63% |
| 2016 | 32.3 Billion EUR | 4.28% |
| 2015 | 30.97 Billion EUR | 9.26% |
| 2014 | 28.35 Billion EUR | 6.75% |
| 2013 | 26.55 Billion EUR | -8.67% |
| 2012 | 29.07 Billion EUR | 0.39% |
| 2011 | 28.96 Billion EUR | -10.24% |
| 2010 | 32.26 Billion EUR | 5.71% |
| 2009 | 30.52 Billion EUR | -3.97% |
| 2008 | 31.79 Billion EUR | -12.66% |
| 2007 | 36.39 Billion EUR | -5.45% |
| 2006 | 38.49 Billion EUR | 13.78% |
| 2005 | 33.83 Billion EUR | 10.21% |
| 2004 | 30.7 Billion EUR | 6.05% |
| 2003 | 28.94 Billion EUR | -10.42% |
| 2002 | 32.31 Billion EUR | -16.1% |
| 2001 | 38.52 Billion EUR | -0.33% |
| 2000 | 38.64 Billion EUR | 30.65% |
| 1999 | 29.58 Billion EUR | 5.67% |
| 1998 | 27.99 Billion EUR | 4.96% |
| 1997 | 26.67 Billion EUR | 5.0% |
| 1996 | 25.4 Billion EUR | 0.19% |
| 1995 | 25.35 Billion EUR | 12.16% |
| 1994 | 22.6 Billion EUR | 5.87% |
| 1993 | 21.35 Billion EUR | -3.9% |
| 1992 | 22.22 Billion EUR | 1.92% |
| 1991 | 21.8 Billion EUR | -2.37% |
| 1990 | 22.33 Billion EUR | -8.01% |
| 1989 | 24.27 Billion EUR | 7.7% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 29.47 Billion EUR | 0.0% |
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q3 | - EUR | -100.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q4 | 29.4 Billion EUR | 0.0% |
| 2023 Q2 | 29.5 Billion EUR | 2515.78% |
| 2023 Q1 | 1.12 Billion USD | -96.32% |
| 2023 FY | 29.4 Billion EUR | -4.18% |
| 2022 Q2 | 32.49 Billion EUR | 0.0% |
| 2022 Q4 | 30.68 Billion EUR | 0.0% |
| 2022 FY | 30.68 Billion EUR | -0.88% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2021 Q2 | 29 Billion EUR | 0.0% |
| 2021 Q4 | 30.96 Billion EUR | 0.0% |
| 2021 FY | 30.96 Billion EUR | 11.72% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2020 Q2 | 27.48 Billion EUR | 0.0% |
| 2020 Q4 | 27.71 Billion EUR | 0.0% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 FY | 27.71 Billion EUR | 2.71% |
| 2020 Q3 | - EUR | -100.0% |
| 2019 Q4 | 26.98 Billion EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q2 | 26.35 Billion EUR | 0.0% |
| 2019 Q3 | - EUR | -100.0% |
| 2019 FY | 26.98 Billion EUR | 3.7% |
| 2018 Q2 | 24.82 Billion EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q4 | 26.01 Billion EUR | 0.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 FY | 26.01 Billion EUR | 2.78% |
| 2017 Q4 | 25.31 Billion EUR | -17.48% |
| 2017 FY | 25.31 Billion EUR | -21.63% |
| 2017 Q1 | 31.86 Billion EUR | -1.36% |
| 2017 Q2 | 29.42 Billion EUR | -7.64% |
| 2017 Q3 | 30.67 Billion EUR | 4.24% |
| 2016 Q3 | 30.91 Billion EUR | -0.56% |
| 2016 Q1 | 29.75 Billion EUR | -3.94% |
| 2016 Q2 | 31.08 Billion EUR | 4.46% |
| 2016 Q4 | 32.3 Billion EUR | 4.51% |
| 2016 FY | 32.3 Billion EUR | 4.28% |
| 2015 Q3 | 30.18 Billion EUR | -2.26% |
| 2015 Q1 | 31.79 Billion EUR | 12.14% |
| 2015 Q4 | 30.97 Billion EUR | 2.61% |
| 2015 FY | 30.97 Billion EUR | 9.26% |
| 2015 Q2 | 30.88 Billion EUR | -2.85% |
| 2014 Q1 | 25.97 Billion EUR | -2.2% |
| 2014 Q4 | 28.35 Billion EUR | 1.55% |
| 2014 Q3 | 27.92 Billion EUR | 8.81% |
| 2014 Q2 | 25.65 Billion EUR | -1.21% |
| 2014 FY | 28.35 Billion EUR | 6.75% |
| 2013 Q1 | 28.72 Billion EUR | -1.21% |
| 2013 FY | 26.55 Billion EUR | -8.67% |
| 2013 Q2 | 27.62 Billion EUR | -3.83% |
| 2013 Q4 | 26.55 Billion EUR | -2.8% |
| 2013 Q3 | 27.32 Billion EUR | -1.09% |
| 2012 Q1 | 29.63 Billion EUR | 2.31% |
| 2012 Q2 | 29.2 Billion EUR | -1.44% |
| 2012 FY | 29.07 Billion EUR | 0.39% |
| 2012 Q4 | 29.07 Billion EUR | 0.01% |
| 2012 Q3 | 29.07 Billion EUR | -0.45% |
| 2011 Q1 | 29.97 Billion EUR | -7.1% |
| 2011 FY | 28.96 Billion EUR | -10.24% |
| 2011 Q3 | 27.71 Billion EUR | 2.1% |
| 2011 Q4 | 28.96 Billion EUR | 4.53% |
| 2011 Q2 | 27.14 Billion EUR | -9.46% |
| 2010 Q2 | 34.31 Billion EUR | 7.68% |
| 2010 FY | 32.26 Billion EUR | 5.71% |
| 2010 Q1 | 31.86 Billion EUR | 4.39% |
| 2010 Q4 | 32.26 Billion EUR | -0.56% |
| 2010 Q3 | 32.45 Billion EUR | -5.43% |
| 2009 Q3 | 29.37 Billion EUR | 1.14% |
| 2009 Q4 | 30.52 Billion EUR | 3.92% |
| 2009 Q2 | 29.04 Billion EUR | -8.53% |
| 2009 Q1 | 31.75 Billion EUR | -3.9% |
| 2009 FY | 30.52 Billion EUR | -3.97% |
| 2008 Q2 | 34.01 Billion EUR | -10.32% |
| 2008 FY | 31.79 Billion EUR | -12.66% |
| 2008 Q1 | 37.92 Billion EUR | 4.19% |
| 2008 Q3 | 34.04 Billion EUR | 0.11% |
| 2008 Q4 | 33.04 Billion EUR | -2.96% |
| 2007 Q4 | 36.39 Billion EUR | 2.71% |
| 2007 Q3 | 35.43 Billion EUR | -3.11% |
| 2007 FY | 36.39 Billion EUR | -5.45% |
| 2007 Q1 | 37.32 Billion EUR | -3.04% |
| 2007 Q2 | 36.57 Billion EUR | -2.02% |
| 2006 Q4 | 38.49 Billion EUR | -2.13% |
| 2006 Q3 | 39.33 Billion EUR | 8.46% |
| 2006 Q1 | 38.27 Billion EUR | 13.12% |
| 2006 FY | 38.49 Billion EUR | 13.78% |
| 2006 Q2 | 36.26 Billion EUR | -5.25% |
| 2005 Q1 | 30.33 Billion EUR | -1.2% |
| 2005 FY | 33.83 Billion EUR | 10.21% |
| 2005 Q4 | 33.83 Billion EUR | 3.3% |
| 2005 Q3 | 32.75 Billion EUR | 4.8% |
| 2005 Q2 | 31.25 Billion EUR | 3.05% |
| 2004 Q4 | 30.7 Billion EUR | -1.32% |
| 2004 FY | 30.7 Billion EUR | 6.05% |
| 2004 Q1 | 31.02 Billion EUR | 7.16% |
| 2004 Q2 | 31.01 Billion EUR | -0.04% |
| 2004 Q3 | 31.11 Billion EUR | 0.33% |
| 2003 Q4 | 28.94 Billion EUR | -4.71% |
| 2003 FY | 28.94 Billion EUR | -10.42% |
| 2003 Q3 | 30.38 Billion EUR | 0.35% |
| 2003 Q2 | 30.27 Billion EUR | -3.99% |
| 2003 Q1 | 31.53 Billion EUR | -2.43% |
| 2002 FY | 32.31 Billion EUR | -16.1% |
| 2002 Q1 | 38.69 Billion EUR | 0.46% |
| 2002 Q2 | 35.35 Billion EUR | -8.64% |
| 2002 Q3 | 35.25 Billion EUR | -0.27% |
| 2002 Q4 | 32.31 Billion EUR | -8.34% |
| 2001 FY | 38.52 Billion EUR | -0.33% |
| 2001 Q2 | 38.83 Billion EUR | -1.65% |
| 2001 Q1 | 39.49 Billion EUR | 2.18% |
| 2001 Q3 | 41 Billion EUR | 5.58% |
| 2001 Q4 | 38.52 Billion EUR | -6.06% |
| 2000 Q1 | 30.86 Billion EUR | 4.34% |
| 2000 FY | 38.64 Billion EUR | 30.65% |
| 2000 Q2 | 34.15 Billion EUR | 10.66% |
| 2000 Q3 | 36.34 Billion EUR | 6.4% |
| 2000 Q4 | 38.64 Billion EUR | 6.34% |
| 1999 FY | 29.58 Billion EUR | 5.67% |
| 1999 Q2 | 27.42 Billion EUR | -4.55% |
| 1999 Q1 | 28.73 Billion EUR | 2.63% |
| 1999 Q3 | 27.77 Billion EUR | 1.28% |
| 1999 Q4 | 29.58 Billion EUR | 6.51% |
| 1998 Q1 | 27.44 Billion EUR | 2.9% |
| 1998 FY | 27.99 Billion EUR | 4.96% |
| 1998 Q4 | 27.99 Billion EUR | 20.4% |
| 1998 Q3 | 23.25 Billion EUR | -1.71% |
| 1998 Q2 | 23.65 Billion EUR | -13.81% |
| 1997 Q1 | 26.3 Billion EUR | 3.55% |
| 1997 FY | 26.67 Billion EUR | 5.0% |
| 1997 Q4 | 26.67 Billion EUR | -2.05% |
| 1997 Q3 | 27.23 Billion EUR | 2.99% |
| 1997 Q2 | 26.44 Billion EUR | 0.52% |
| 1996 Q4 | 25.4 Billion EUR | 0.0% |
| 1996 FY | 25.4 Billion EUR | 0.19% |
| 1995 FY | 25.35 Billion EUR | 12.16% |
| 1995 Q4 | 25.35 Billion EUR | 0.0% |
| 1994 Q4 | 22.6 Billion EUR | 0.0% |
| 1994 FY | 22.6 Billion EUR | 5.87% |
| 1993 Q4 | 21.35 Billion EUR | 0.0% |
| 1993 FY | 21.35 Billion EUR | -3.9% |
| 1992 Q4 | 22.22 Billion EUR | 0.0% |
| 1992 FY | 22.22 Billion EUR | 1.92% |
| 1991 FY | 21.8 Billion EUR | -2.37% |
| 1991 Q4 | 21.8 Billion EUR | 0.0% |
| 1990 Q4 | 22.33 Billion EUR | 0.0% |
| 1990 FY | 22.33 Billion EUR | -8.01% |
| 1989 Q4 | 24.27 Billion EUR | 0.0% |
| 1989 FY | 24.27 Billion EUR | 7.7% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Abbott Laboratories | 73.21 Billion USD | 59.836% |
| Allurion Technologies Inc. | 71.71 Million USD | -40905.689% |
| Artivion, Inc. | 792.39 Million USD | -3611.019% |
| Avanos Medical, Inc. | 1.69 Billion USD | -1637.532% |
| Butterfly Network, Inc. | 304.27 Million USD | -9564.316% |
| Butterfly Network, Inc. | 304.27 Million USD | -9564.316% |
| Bio-Rad Laboratories, Inc. | 12.29 Billion USD | -139.091% |
| Boston Scientific Corporation | 35.13 Billion USD | 16.308% |
| CONMED Corporation | 2.3 Billion USD | -1178.51% |
| Edwards Lifesciences Corporation | 9.36 Billion USD | -214.059% |
| Paragon 28, Inc. | 340.69 Million USD | -8531.079% |
| Glaukos Corporation | 940.41 Million USD | -3026.921% |
| Globus Medical, Inc. | 5.08 Billion USD | -478.166% |
| Inspire Medical Systems, Inc. | 676.81 Million USD | -4244.788% |
| Integer Holdings Corporation | 2.94 Billion USD | -899.302% |
| Medtronic plc | 89.98 Billion USD | 67.32% |
| Myomo, Inc. | 14.58 Million USD | -201565.555% |
| Nevro Corp. | 635.71 Million USD | -4525.672% |
| Owlet, Inc. | 44.12 Million USD | -66545.514% |
| Penumbra, Inc. | 1.55 Billion USD | -1789.475% |
| Vicarious Surgical Inc. | 119.86 Million USD | -24432.804% |
| Smith & Nephew plc | 9.98 Billion USD | -194.443% |
| STERIS plc | 11.06 Billion USD | -165.788% |
| Stryker Corporation | 39.91 Billion USD | 26.323% |
| Vapotherm, Inc. | 77.61 Million USD | -37786.03% |
| Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | -36.792% |